ArticleCell cycle (Georgetown, Tex.)2013

PP2A(Cdc55/B55), a possible therapeutic target in cyclin D1-dependent cancers.

Eishi NoguchiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.